Priority Review
FDA & Regulatory
Priority Review shortens the FDA’s target review time from the standard ~10 months to ~6 months for drugs that would significantly improve the treatment of a serious condition. It is granted at filing and is often paired with a Priority Review Voucher in qualifying cases.
Related terms
Learn more
Track Priority Review across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free